Business first reported 6d ago by Benzinga · updated 6d ago GH Research's $1.2B Depression Drug Opportunity Still Has Analysts Buying the Dip Photo: Benzinga ▲ Sign in to vote stories up Coverage 1 source · 1 report Chronological. Benzinga FIRST 6d ago GH Research's $1.2B Depression Drug Opportunity Still Has Analysts Buying the Dip Related stories Sports Sources: Mayfield dealing with plantar fasciitis, determined to keep playing 2 sources Sports Tom Jackson, Broncos' Orange Crush linebacker and ESPN legend, dead at 75 8 sources Technology Datacentre bosses met Australian state premiers and ministers almost 120 times in three years, analysis finds 2 sources Sports AP Top 25 Poll Prediction: How Far Will UCLA, Ohio State and Indiana Drop? 2 sources Discussion 0 comments Sign in to join the discussion. ← Front page
Discussion 0 comments